Sign in to continue:

Wednesday, July 29th, 2026

Ponce Financial Group Reports Strong Loan Growth, Rising Earnings, and Robust Capital Ratios in 2026 Financial Results





Ponce Financial Group, Inc. Reports Strong Q2 2026 Results; ECIP Preferred Stock Repurchase Progress

Ponce Financial Group, Inc. Delivers Robust Q2 2026 Results and Signals Potential Preferred Stock Repurchase

Key Financial Highlights for Investors

  • Net Income: For Q2 2026, net income available to common stockholders reached \$8.2 million, or \$0.35 per diluted share, compared to \$8.3 million (\$0.36 per share) in Q1 2026 and \$5.8 million (\$0.25 per share) in Q2 2025. Total net income for Q2 2026 stood at \$8.5 million.
  • Six-Month Performance: Net income available to common stockholders for the first half of 2026 was \$16.6 million (\$0.71 per diluted share), up 44% from \$11.5 million (\$0.50 per diluted share) in the prior year period.
  • Net Interest Income and Margin: Q2 2026 net interest income was \$30.1 million, up 6.5% sequentially and 23.1% year-over-year. Net interest margin expanded to 3.66% (up from 3.61% in Q1 2026 and 3.27% in Q2 2025).
  • Dividend Payments: The company paid \$0.3 million in preferred stock dividends in Q2 and \$0.6 million in H1 2026.
  • Book Value: Book value per common share increased to \$13.89, up \$1.55 (13%) year-over-year.
  • Asset Quality: Allowance for credit losses on loans as a percentage of total loans remained steady at approximately 0.95%. Net charge-offs were minimal at (0.05%) of average outstanding loans.
  • Balance Sheet Strength: Cash and equivalents rose to \$140.0 million (up 11% from year-end 2025). Securities totaled \$338.4 million, down 7.3% due to principal payments and maturity of one available-for-sale security.
  • Capital Ratios: The company maintains strong capital levels, with total capital to risk-weighted assets at 20.0% and CET1 ratio (holding company) at 11.51%. The bank-only CET1 ratio is a robust 17.87%.

Strategic and Price-Sensitive Developments

  • ECIP Preferred Stock Repurchase Progress: Executive Chairman Steven A. Tsavaris announced that, following the Q2 2026 Quarterly Supplemental Report, Ponce believes it has met the lending conditions required to repurchase its Preferred Stock issued under the U.S. Treasury’s Emergency Capital Investment Program (ECIP). The company is now moving toward satisfying additional eligibility criteria under the ECIP Purchase Option Agreement.

    • Potential Impact: While the consummation of the repurchase is subject to regulatory approval and the satisfaction of further conditions, this move could be highly price-sensitive, reducing the cost of capital, eliminating preferred stock dividends, and increasing common shareholder value. However, management cautions that there can be no assurance of timing or certainty of consummation.
  • Efficiency Ratio: The efficiency ratio for Q2 2026 was 57.41%, a slight increase from 56.96% in Q1 2026, but an improvement from 63.69% in Q2 2025, reflecting ongoing investments in operational efficiency and technology.
  • Loan and Deposit Growth: The company reported strong loan and deposit growth during the quarter, reinforcing its community banking focus and expansion potential.

Management Commentary

“Our net income per share of \$0.71 year to date is up 42% versus the same period last year and our book value per share of \$13.89 is up \$1.55 or 13% over the same period. Net interest margin is up 5 basis points versus last quarter and 39 basis points versus the same quarter last year. Our capital ratios continue to be well in excess of regulatory requirements. We remain committed to the communities we serve, and we’ll continue investing in our people and in technology to improve our efficiency.”

— Carlos P. Naudon, President and CEO

“We’re pleased with our strong loan and deposit growth this quarter. We’ve filed our Q2 2026 QSR and believe we have met the necessary lending conditions to repurchase our Preferred Stock under the ECIP Purchase Option Agreement… We are excited about this milestone and the possibilities that the repurchase regulatory process will bring to the Company.”

— Steven A. Tsavaris, Executive Chairman

Detailed Financials and Metrics

  • Return on Average Assets (ROAA): 1.00% for Q2 2026, down from 1.07% in Q1 but up from 0.79% in Q2 2025.
  • Return on Common Equity (ROE): 9.81% for Q2 2026, down from 10.37% in Q1 but up from 7.98% in Q2 2025.
  • Net Interest Income: \$30.1 million in Q2 2026, an increase of \$1.8 million from Q1 and \$5.6 million from Q2 2025.
  • Non-Interest Income: \$1.5 million in Q2 2026, down \$0.5 million from Q1 and \$0.5 million from Q2 2025, primarily due to lower late/prepayment charges and no income from SBA loan sales or grants in the current period.
  • Non-Interest Expense: \$18.1 million in Q2 2026, up \$0.9 million sequentially and \$1.3 million year-over-year, reflecting ongoing investments in personnel and technology.
  • Provision for Credit Losses: \$2.1 million in Q2 2026, up from \$1.7 million in Q1 2026 and \$1.1 million in Q2 2025.
  • Deposits: Total NOW, money market, reciprocal, and savings accounts were \$1.28 billion as of June 30, 2026, up from \$1.22 billion at year-end 2025.
  • Outstanding Common Shares: 24,187,901 at June 30, 2026.

Forward-Looking Statements

Management noted that forward-looking statements regarding financial outlook, capital actions (including ECIP preferred stock repurchase), and strategic initiatives are subject to risks and uncertainties, including regulatory approvals, market conditions, changes in interest rates, and the broader economic environment.

Conclusion

Investor Takeaway: Ponce Financial Group delivered another quarter of solid growth, highlighted by significant earnings momentum, improved profitability metrics, and robust capital ratios. The potential repurchase of ECIP Preferred Stock is a major price-sensitive development that, if completed, could materially enhance common shareholder value and further improve the company’s financial flexibility. Investors should monitor regulatory progress on this front, as well as ongoing credit and expense trends in future quarters.


Disclaimer: This article is for informational purposes only and does not constitute investment advice. Forward-looking statements are inherently subject to risks and uncertainties that could cause actual results to differ materially. Investors should review all filings and disclosures, and consult their financial advisors before making investment decisions.




View Ponce Financial Group, Inc. Historical chart here



Nobility Homes Inc. 8-K Filing March 2026: Executive Compensation Vote & Corporate Information

Nobility Homes, Inc. Amends 2011 Stock Incentive Plan and An...

MoonLake Immunotherapeutics Signs Manufacturing Agreement with Vetter Pharma – SEC 8-K Filing Details 8

MoonLake Immunotherapeutics - 8-K Filing Analysis Moon...

MiniMed: Full-Stack Diabetes Therapy Company Revolutionizing Automated Insulin Delivery and Smart Dosing Systems 15161718

MiniMed Group, Inc. IPO Report: Key Insights and Shareholder...